AIM: NanoKnife(®) (Angiodynamics, Inc., NY, USA) or irreversible electroporation (IRE) is a newly available ablation technique to induce the formation of nanoscale pores within the cell membrane in targeted tissues. The purpose of this study was to elucidate morphological alterations following 30 min of IRE ablation in a mouse model of pancreatic cancer. MATERIALS & METHODS: Immunohistochemistry markers were compared with diffusion-weighted MRI apparent diffusion coefficient measurements before and after IRE ablation. RESULTS: Immunohistochemistry apoptosis index measurements were significantly higher in IRE-treated tumors than in controls. Rapid tissue alterations after 30 min of IRE ablation procedures (structural and morphological alterations along with significantly elevated apoptosis markers) were consistently observed and well correlated to apparent diffusion coefficient measurements. DISCUSSION: This imaging assay offers the potential to serve as an in vivo biomarker for noninvasive detection of tumor response following IRE ablation.
AIM: NanoKnife(®) (Angiodynamics, Inc., NY, USA) or irreversible electroporation (IRE) is a newly available ablation technique to induce the formation of nanoscale pores within the cell membrane in targeted tissues. The purpose of this study was to elucidate morphological alterations following 30 min of IRE ablation in a mouse model of pancreatic cancer. MATERIALS & METHODS: Immunohistochemistry markers were compared with diffusion-weighted MRI apparent diffusion coefficient measurements before and after IRE ablation. RESULTS: Immunohistochemistry apoptosis index measurements were significantly higher in IRE-treated tumors than in controls. Rapid tissue alterations after 30 min of IRE ablation procedures (structural and morphological alterations along with significantly elevated apoptosis markers) were consistently observed and well correlated to apparent diffusion coefficient measurements. DISCUSSION: This imaging assay offers the potential to serve as an in vivo biomarker for noninvasive detection of tumor response following IRE ablation.
Authors: S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman Journal: Radiology Date: 2005-04-21 Impact factor: 11.105
Authors: Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee Journal: Radiology Date: 2010-05 Impact factor: 11.105
Authors: Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Bin Wang; Chong Sun; Junjie Shangguan; Liang Pan; Kang Zhou; Quanhong Ma; Vahid Yaghmai; Daniele Procissi; Andrew C Larson; Zhuoli Zhang Journal: Am J Cancer Res Date: 2018-08-01 Impact factor: 6.166
Authors: Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert Journal: Langenbecks Arch Surg Date: 2017-04-04 Impact factor: 3.445
Authors: Xifu Wang; Zhanliang Su; Tianchu Lyu; Matteo Figini; Daniel Procissi; Junjie Shangguan; Chong Sun; Bin Wang; Na Shang; Shanzhi Gu; Quanhong Ma; Andrew C Gordon; Kai Lin; Jian Wang; Robert J Lewandowski; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang Journal: Radiology Date: 2017-12-12 Impact factor: 11.105
Authors: Vincenza Granata; Roberta Fusco; Simona Salati; Antonella Petrillo; Elio Di Bernardo; Roberta Grassi; Raffaele Palaia; Ginevra Danti; Michelearcangelo La Porta; Matteo Cadossi; Gorana Gašljević; Gregor Sersa; Francesco Izzo Journal: Int J Environ Res Public Health Date: 2021-05-24 Impact factor: 3.390